Merck asks FDA to authorize promising anti-COVID pill
Drugmaker Merck asked U.S. regulators Monday to authorize its pill for treating COVID-19 in what would add an entirely new and easy-to-use weapon to the world's arsenal against the pandemic.
57 across the spectrum. Choose a side on the bar to jump to it.
National story. 150 articles from 58 sources. 57 are on the bar; 1 is an international, entertainment or tech outlet, listed separately. Updated Oct 12, 2021.
Left
16 sourcesMerck requests FDA authorization for its anti-COVID-19 pill, the next step towards rolling it out
Center
30 sourcesMerck Covid-19 treatment pill 'a very powerful tool to add to the toolbox'
Merck Reportedly Plans To Double Production Of New Covid-Fighting Pill As Wealthy Countries Corner Scarce Supplies
Merck submits emergency use authorization for COVID-19 pill
Right
11 sourcesMerck seeks first U.S. authorization for COVID-19 pill
Other outlets
International, entertainment and tech outlets, by their rating. Not counted in the bar above. How we count coverage
Left
1 articleCenter
0 articlesNone
Right
0 articlesNone
The story so far
2 developments- Oct 11, 2021Merck asks FDA to authorize promising anti-COVID pill
- Oct 12, 2021Only center coverage:Merck Reportedly Plans To Double Production Of New Covid-Fighting Pill As Wealthy Countries Corner Scarce Supplies
Who covered each development
No new developments
Quiet for 1836 daysLast development · Oct 12, 2021 — Merck Reportedly Plans To Double Production Of New Covid-Fighting Pill As Wealthy Countries Corner Scarce Supplies